$QSI Cashflow Statement | Understand Stock

$QSI

$1.63 -$0.02 (1.12%) After hours

$QSI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Unrealized losses of marketable securities
Allowance for credit losses
Non-cash lease expense
(Gain) loss on marketable securities, net
Loss on lease termination
Write-off of construction on process due to lease termination
Unrealized gain on trading securities, net
Realized loss on trading securities
Accretion on marketable securities
Loss on disposal of fixed assets
Write-down of inventory
Goodwill impairment
Change in fair value of warrant liabilities
Change in fair value of contingent consideration
Change in fair value of stock consideration
Stock-based compensation
Write-off of intellectual property
Other
Changes in operating assets and liabilities:
Accounts receivable, net
Legal settlement insurance receivable
Inventory
Prepaid expenses and other current assets
Operating lease right-of-use assets
Other assets
Other assets - related party
Accounts payable
Accrued expenses and other current liabilities
Short-term operating lease liabilities
Accrued legal settlement liability
Other long-term liabilities
Operating lease liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Internally developed software - capitalized costs
Purchases of marketable securities
Sales and maturities of marketable securities
Business acquisition
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Proceeds from exercise of stock options
Proceeds from issuance of Series E convertible preferred stock
Net proceeds from equity infusion from the Business Combination
Payment of notes payable
Proceeds from vesting of restricted stock
Proceeds from issuance of common stock from direct equity offerings and the exercise of public and pre-funded warrants, net of fees and issuance costs
Proceeds from issuance of common stock from “at-the-market” offering, net of commissions and issuance costs
Deferred offering costs
Payment of contingent consideration - business acquisition
Payment of deferred consideration - business acquisition
Principal payments under finance lease obligations
Refund of issuance costs
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Cash received from exchange of research and development tax credits
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:
Property and equipment purchased but not paid
Transfers from inventory to property and equipment
Deferred offering costs payable
Forgiveness of related party promissory notes
Noncash equity issuance - business acquisition
Noncash equity related warrants from the Business Combination
Conversion of the convertible preferred stock into Class A and Class B common stock
Noncash contingent consideration and holdbacks - business acquisition

Comments